Webinar
SHARE
SHARE
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is accepting letters of intent now through Monday, November 3, 2025, for its third round of funding. Funded projects will be eligible for up to $500,000 over two years, inclusive of indirect costs.
The program supports two-year research projects at the basic or early-stage translational stages that are designed to elucidate the fundamental biology of why and how sporadic forms of FTD develop.
Potential applicants are invited to watch an informational webinar about this grant cycle above. The webinar was held on Tuesday, October 14, 2025.
Interested applicants must submit a letter of intent by November 3, 2025, to be considered for the program’s third round of funding. Please see the full Request for Proposals for additional information.
SHARE
Related Content
-
Kissick Family Foundation FTD Grant Program: 2025 Awardees and Projects
In September 2025, the Kissick Family Foundation, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), awarded four two-year grants to basic and early-stage translational research...Read Article -
A Global Imperative to Improve Brain Health
Age-related neurological and psychiatric diseases—including dementia, stroke, and late-life depression (LLD)—remain a major and growing public health challenge, as the global population over age 60 is expected to double by 2050.Read Report
KP
SP
TP
-
Kissick Family Foundation, Milken Institute Announce $2 Million in Funding for Frontotemporal Dementia Research and New Call for Proposals
September 15, 2025 (Washington, DC)—The Kissick Family Foundation, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), today announced that the Kissick Family Foundation...Read ArticleImage
Sam Roth
Associate Director, Media RelationsSam Roth is the associate director of media relations for the Milken Institute. Based out of the Washington, DC, office, she oversees media coverage for the Health and Strategic Philanthropy pillars. -
Uterine Leiomyosarcoma: A Giving Smarter Guide
This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...Read ReportIP
-
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that has challenged patients, their families, and the medical community for generations. Although ALS is considered rare, its impact on...Read Report
MH
-
Milken Institute, Ann Theodore Foundation Launch New Grant to Support Clinical Trial for Potential Sarcoidosis Treatment
February 20, 2026 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future...Read Article -
Request for Proposals: Ann Theodore Foundation Sarcoidosis Inhibitor of mTOR (SIM) Trial
The Ann Theodore Foundation (ATF) is launching a new funding program to support the study of repurposed mechanistic target of rapamycin (mTOR) inhibitors as treatments for cutaneous sarcoidosis. This program will be executed in partnership...Read Article -
Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program (2025-2026)
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund a third cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop. In partnership with the Milken...Read Article